IQVIA China

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research.
Partnering Objectives
Headquartner in China
竹芸 郭
Senior consultant 

iX Biopharma Ltd Singapore

iX Biopharma is established in 2008, and listed on Singapore Stock Exchange (Catalist Board) in 2015. iX is a specialist in novel wafer formulations using patented sublingual delivery technology, WaferiXTM , which is patented in China to 2033. R&D and manufacturing at wholly-owned GMP licensed facility in Melbourne, Australia.
Company Size (Fulltime employees)
Year of foundation
2008
Please specify your partnering goal
(1) Licensing Partner (2) Sublingual wafer development technology collaboration
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Yuhuan Wang
Senior BD Manager 
Functionality

Jiangsu Carephar Pharmaceutical Co.,Ltd China

Jiangsu Carephar Pharmaceutical Co.,Ltd
Website:
www.carephar.com
Headquartner in China
yu hui
BD 
Functionality

Jiangxi Jemincare Group Co., Ltd. China

One Top Chinese Pharma

Ben Yang
Business Development Manager 

JNJ United States

Pharmaceutical
Website:
www.JNJ.com
Company Size (Fulltime employees)
Please specify your partnering goal
Therapeutic
Headquartner in China
Dr. Jack Zhao
Principal 

Kaitai Capital China

Kaitai is a biotech venture fund with about 40 biotech portfolio companies. Kaitai's fund size is about 7 billions dollars. They are positively looking for cutting edge technologies.
Partnering Objectives
Headquartner in China
Eric Chang
Executive Director 
Qi Jin
董事总裁 

Kerry United States

Bio ingredients supplier
Website:
Www.kerry.com
Company Size (Fulltime employees)
Year of foundation
1976
Partnering Objectives
Please specify your partnering goal
Market insight
Headquartner in China
Mr. Jacob Jeong
BD Director 
Functionality

Kymeris therapeutics Inc Canada

Kymeris has invented a revolutionary, live-cell based technology platform which delivers into the tumor micro-environment and activates there multiple therapeutic agents - including ligands, cytokines, and antibodies. Efficacy of anti-cancer action has been shown in 5 separate solid cancer indications with reduction in tumour size averaging 80% - but in many cases showing complete eradication. This game changing approach is of particular value to companies with proprietary molecules that are looking for safe and effective vectoring into tumors, and with whom we might partner.
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
Out licensing
Headquartner in China
Biotech/Pharma Category
Mr. Richard McCrae
President & CEO 
Functionality

L.E.K. China

L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. Founded 38 years ago, L.E.K. employs more than 1,400 professionals around the world. L.E.K. entered China in 1998 and has since become a leading commercial advisor in life sciences and healthcare services practices, covering all aspects of the industry value chain and life cycle. Supported by the Singapore Economic Development Board, L.E.K. established The APAC Life Sciences Centre of Excellence, aiming to provide life sciences companies in APAC with useful insights and practical knowledge, including best practices from other markets around the world. For more information, go to www.lek.com

Website:
www.lek.com
Company Size (Fulltime employees)
Year of foundation
1983
Partnering Objectives
Mr Elvis Zhang
Business Development Director 

Lauren Craig Consulting LLC United States

Consulting services with expertise in sales, business development and market access.
Website:
Seelinkedin
Company Size (Fulltime employees)
Please specify your partnering goal
Investing and Pitch Services
Headquartner in China
Ms. Lauren Craig, MBA CPC-H
Founder 
Functionality